BMBei Mao

Bei Mao

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Bei Mao has a total of 13 co-authors. Here are the top co-authors by number of shared publications:

  • Chuantong Xie

    Department of Endocrinology and Metabolism of Huashan Hospital, State Key Laboratory of Brain Function and Disorders, MOE Frontiers Center for Brain Science and the Institutes of Brain Science, Fudan University, Shanghai, China

    1 shared publication
  • Chuxin Huang

    Huashan Hospital 3 Department of Endocrinology Fudan University, Shanghai, PR China

    1 shared publication
  • Lei Xiao

    State Key Laboratory of Brain Function and Disorders, MOE Frontiers Center for Brain Science, Institutes of Brain Science, Fudan University, Shanghai, China

    1 shared publication
  • Linling Fan

    Department of Endocrinology and Metabolism of Huashan Hospital, State Key Laboratory of Brain Function and Disorders, MOE Frontiers Center for Brain Science and the Institutes of Brain Science, Fudan University, Shanghai, China

    1 shared publication
  • Min He

    Department of Endocrinology and Metabolism, Huashan Hospital, Fudan University, Shanghai, China

    1 shared publication
  • Quanya Sun

    Department of Endocrinology and Metabolism, Huashan Hospital, Fudan University, Shanghai, China

    1 shared publication

Latest Publications

  • Open Access

    Type IIB PKA serves as the primary effector of Gs-coupled receptor-potentiated insulin secretion in mice by orchestrating ion channels and granule phenotype

    by Ying Liu, Yunzhi Ni, Chuantong Xie, Linling Fan, Yaojing Jiang, Quanya Sun, Bei Mao, Chuxin Huang, Zhaoyun Zhang, Yehong Yang, et al.

    Aims/hypothesis: G-protein-coupled receptors (GPCRs) play an important role in maintaining systemic glucose homeostasis by regulating insulin secretion, with protein kinase A (PKA) signalling serving as a key downstream effector. Our previous work identified specific expression of type IIB PKA in pancreatic beta cells. Based on these findings, we propose that type IIB PKA is involved in mediating the GPCR signalling in pancreatic beta cells. Methods: The glucagon-like peptide-1 (GLP-1) analogue liraglutide was administered to mice 30 min before glucose injection during an IPGTT, whereas the glucose levels and insulin levels were measured in wild-type and RIIβ-knockout mice. The isolated islets were subjected to both perifusion assay and static batch incubations following stimulation with liraglutide, glucagon and follicle-stimulating hormone (FSH). RNA-seq analysis was performed to identify molecular changes in islets with RIIβ ablation. Both western blotting and quantitative PCR were employed to quantify the gene expression. Whole-cell patch-clamp recordings were conducted to measure K ATP and Ca 2+ currents. Insulin granule morphology and abundance were evaluated by electron microscopy and flow cytometry using EGFP-labelled Syncollin, respectively. Results: RIIβ-knockout mice exhibited impaired glucose tolerance and attenuated insulin secretion in response to liraglutide. Islets isolated from RIIβ-knockout mice showed reduced insulin secretion following liraglutide stimulation. Similarly, RIIβ-ablated islets displayed decreased insulin secretion in response to both glucagon and FSH. Further mechanistic studies revealed that RIIβ deficiency impaired liraglutide-mediated PKA signalling activation. Specifically, RIIβ-ablated beta cells exhibited reduced basal K ATP channel activity and lack of liraglutide-mediated channel inhibition. Multiple voltage-gated Ca 2+ channel genes were downregulated in RIIβ-ablated islets, leading to a mild reduction in basal Ca 2+ current and a significant decrease following liraglutide treatment. RIIβ-knockout beta cells also exhibited reduced insulin granule size, decreased total granule number and fewer granules docked at the plasma membrane. Conclusions/interpretation: Our results highlight type IIB PKA as a primary mediator of Gs-coupled receptor-potentiated insulin secretion, providing a new molecular framework for metabolic regulation research.